Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Ramesh Arasaradnam"'
Publikováno v:
mSphere, Vol 8, Iss 2 (2023)
ABSTRACT Taxonomic composition of the gut microbiota in colorectal cancer (CRC) patients is altered, a newly recognized driving force behind the disease, the activity of which has been overlooked. We conducted a pilot study on active microbial taxono
Externí odkaz:
https://doaj.org/article/48673db5c3ce4e00a0d3d57bf281da66
Publikováno v:
mSphere, Vol 8, Iss 2 (2023)
ABSTRACT The gut microbiome is implicated in the pathology of colorectal cancer (CRC). However, the mechanisms by which the microbiota actively contribute to disease onset and progression remain elusive. In this pilot study, we sequenced fecal metatr
Externí odkaz:
https://doaj.org/article/483e2e5c163f4b6abb922c78be36cd7b
Autor:
Murad Al-Rajab, Joan Lu, Qiang Xu, Mohamed Kentour, Ahlam Sawsa, Emad Shuweikeh, Mike Joy, Ramesh Arasaradnam
Publikováno v:
PLoS ONE, Vol 18, Iss 11, p e0286791 (2023)
Colon cancer is a significant global health problem, and early detection is critical for improving survival rates. Traditional detection methods, such as colonoscopies, can be invasive and uncomfortable for patients. Machine Learning (ML) algorithms
Externí odkaz:
https://doaj.org/article/0ecd0fa62d1345f292515c6a9f9da46c
Publikováno v:
BMJ Open, Vol 12, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/75fb61a3835d4b3f9cc85b36eac7c652
Autor:
Michael McFarlanE, Ella MozdiaK, Emma Daulton, Ramesh Arasaradnam, James Covington, Chuka Nwokolo
Publikováno v:
PLoS ONE, Vol 15, Iss 7, p e0236591 (2020)
There has been rapidly accelerating interest in the utilization of volatile organic compounds (VOCs) as non-invasive methods for rapid point-of-care medical diagnostics. There is widespread variation in analytical methods and protocols, with little u
Externí odkaz:
https://doaj.org/article/a304d65f41fe41cdba781c7519269f75
Autor:
Ella Mozdiak, Alexander Tsertsvadze, Michael McFarlane, Monika Widlak, Maria Tabuso, Amber Dunlop, Ramesh Arasaradnam
Publikováno v:
Systematic Reviews, Vol 5, Iss 1, Pp 1-7 (2016)
Abstract Background Colorectal cancer represents the fourth most common cancer in England and Wales; survival is high for early stage disease but declines sharply with advanced stage. UK figures suggest that cancer survival rates are lower than those
Externí odkaz:
https://doaj.org/article/28f8ca07d5b5467e8374235afbb3e198
Autor:
Michael McFarlane, John Lin Hieng Wong, Shankara Paneesha, Zbigniew Rudzki, Ramesh Arasaradnam, Chuka Nwokolo
Publikováno v:
Case Reports in Gastroenterology, Vol 10, Iss 2, Pp 241-247 (2016)
Mucosa-associated lymphoid tissue lymphoma (MALToma) is a subtype of B-cell non-Hodgkin’s lymphoma, comprising ∼17% of all gastrointestinal (GI) tract lymphomas. It is associated with chronic inflammation and autoimmunity, for example Helicobacte
Externí odkaz:
https://doaj.org/article/6cc03ce9e98046a69d8c7c80294e72c5
Publikováno v:
Diagnostics, Vol 10, Iss 5, p 338 (2020)
Recent advancement in the immunological understanding of genesis of hepatocellular carcinoma (HCC) has implicated a decline in anti-tumour immunity on the background of chronic inflammatory state of liver parenchyma. The development of HCC involves a
Externí odkaz:
https://doaj.org/article/d8e92aa04729441e94cec146f39321c1
Publikováno v:
Vaccines, Vol 8, Iss 2, p 247 (2020)
A majority of hepatocellular carcinoma (HCC) develops in the setting of persistent chronic inflammation as immunological mechanisms have been shown to play a vital role in the initiation, growth and progression of tumours. The index review has been i
Externí odkaz:
https://doaj.org/article/fbb1641272184745bc914a0da9fa025d
Autor:
Karoline Freeman, Martin Connock, Peter Auguste, Sian Taylor-Phillips, Hema Mistry, Deepson Shyangdan, Rachel Court, Ramesh Arasaradnam, Paul Sutcliffe, Aileen Clarke
Publikováno v:
Health Technology Assessment, Vol 20, Iss 83 (2016)
Background and objectives: Systematic reviews and economic modelling of clinical effectiveness and cost-effectiveness of therapeutic monitoring of tumour necrosis factor alpha (TNF-α) inhibitors [using LISA-TRACKER® enzyme-linked immunosorbent assa
Externí odkaz:
https://doaj.org/article/e379f9d1cf8b42c1a42e2d885ef21502